Contraception in Perimenopause: When to Discontinue

Abstract

Get full access to this article

View all access options for this article.

References

Shifren

, Gass

. The North American Menopause Society recommendations for clinical care of midlife women. Menopause, 2014; 21:1038–1062.

Speroff

, Fritz

, eds. Clinical gynecologic endocrinology and infertility, 7th ed. Philadelphia: Lippincott Williams and Wilkins, 2005:632–633.

Leridon

, Slama

. The impact of a decline in fecundity and of pregnancy postponement on final number of children and demand for assisted reproduction technology. Hum Reprod, 2008; 23:1312–1319.

Centers for Disease Control and Prevention (CDC). U.S. medical eligibility criteria for contraceptive use, 2010. MMWR Rec Rep, 2010; 59(RR-4):1–86.

American Congress of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices. Obstet Gynecol, 2011; 118:184–196.

Calhoun

. Combined hormonal contraceptives: is it time to reassess their role in migraine?. Headache, 2012; 52:648–660.

Shuster

, Faubion

, Sood

, Casey

. Hormonal manipulation strategies in the management of menstrual migraine and other hormonally related headaches. Curr Neurol Neurosci Rep, 2011; 11:131–138.

Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC). U.S. selected practice recommendations for contraceptive use, 2013: Adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. MMWR Recomm Rep, 2013; 62(RR-05):1–60.

Winner

, Peipert

, Zhao

, et al., Effectiveness of long-acting reversible contraception. N Engl J Med, 2012; 366:1998–2007.

10.

Bayer HealthCare. Skyla LNG-IUS package insert. Wayne, NJ: Bayer HealthCare Pharmaceuticals Inc., 2013. Available at: http://labeling.bayerhealthcare.com/html/products/pi/Skyla_PI.pdf Accessed March 18, 2015 .

11.

Marret

, Fauconnier

, Chabbert-Buffet

, et al., Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol Reprod Biol, 2010; 152:133–137.

12.

Merck

Sharp

and Dohme

B.V.

Nexplanon package insert. Whitehouse Station, NJ: Merck & Co., Inc., Merck Sharp & Dohme Corp., 2014. Available at: www.merck.com/product/usa/pi_circulars/n/nexplanon/nexplanon_pi.pdf Accessed March 18, 2015 .

13.

Glasier

, Cameron

, Blithe

, et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception, 2011; 84:363–367.